SLC6A1 and dopa-responsive dystonia due to sepiapterin reductase deficiency: SLC6A1 variants found in individuals with SRD consistently demonstrate reduced GAT1 function and impaired trafficking to the cell surface in cell culture (Mattison et al., 2018; Mermer et al., 2021; Trinidad et al., 2022).